Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial
- PMID: 8272303
Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial
Abstract
Objective: To address the hypothesis that multiphasic oral contraceptives (OCs) increase rather than decrease the risk of functional ovarian cysts.
Methods: In this single-center, randomized controlled study, women were assigned to a multiphasic pill, a lower-dose monophasic pill, a higher-dose monophasic pill, or nonsteroidal contraception. Forty volunteers were randomized (ten each) to three different pill regimens or to nonsteroidal contraception. During 6 months of treatment, follicular development was measured by vaginal ultrasonography and ovulation was indicated by serum progesterone levels.
Results: The relative risk (RR) of developing a follicular structure greater than 30 mm in diameter during a cycle with the higher-dose monophasic pill was 0.5 (95% confidence interval [CI] 0.1-1.9; P = .49) compared with the multiphasic pill. The risk with the lower-dose monophasic pill was comparable to that with the multiphasic pill (RR 1.3, 95% CI 0.5-3.6; P = .56). With the multiphasic pill, the maximum ovulation rate over 60 cycles was 1.7 per 100 cycles (95% CI 0.0-8.9).
Conclusion: This multiphasic pill more closely resembled the lower-dose monophasic pill than the higher-dose monophasic pill in its suppression of follicular development.
Similar articles
-
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.Am J Obstet Gynecol. 2004 Apr;190(4):943-51. doi: 10.1016/j.ajog.2004.02.012. Am J Obstet Gynecol. 2004. PMID: 15118618 Clinical Trial.
-
Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.Hum Reprod. 2004 Nov;19(11):2674-9. doi: 10.1093/humrep/deh494. Epub 2004 Aug 19. Hum Reprod. 2004. PMID: 15319379 Clinical Trial.
-
Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.Contracept Rep. 1994 Mar;5(1):6-9. Contracept Rep. 1994. PMID: 12287739
-
[Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].Zentralbl Gynakol. 1997;119(11):538-44. Zentralbl Gynakol. 1997. PMID: 9480608 Clinical Trial. German.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
Cited by
-
Menstrual migraine: a review of prophylactic therapies.Curr Pain Headache Rep. 2004 Jun;8(3):229-37. doi: 10.1007/s11916-004-0057-1. Curr Pain Headache Rep. 2004. PMID: 15115643 Review.
-
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.Am J Obstet Gynecol. 2012 Jul;207(1):39.e1-6. doi: 10.1016/j.ajog.2012.04.022. Epub 2012 Apr 28. Am J Obstet Gynecol. 2012. PMID: 22727346 Free PMC article. Clinical Trial.
-
Noncontraceptive health benefits of oral contraceptives.Rev Endocr Metab Disord. 2002 Sep;3(3):277-83. doi: 10.1023/a:1020084728544. Rev Endocr Metab Disord. 2002. PMID: 12215722 Review. No abstract available.
-
Oral contraceptives for functional ovarian cysts.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD006134. doi: 10.1002/14651858.CD006134.pub5. Cochrane Database Syst Rev. 2014. PMID: 24782304 Free PMC article. Review.
-
Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use.Contraception. 2011 Nov;84(5):e1-4. doi: 10.1016/j.contraception.2011.05.003. Epub 2011 Jun 16. Contraception. 2011. PMID: 22018131 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources